I gained an interest in research while studying for my BSc in Medicinal Chemistry. Pursuing a career in research I went on to obtain an MSc in Pharmaceutical Science and Medicinal Chemistry, followed by moving to Edinburgh to carry out research for a PhD in a highly translational research lab.
After working in academic research for several years I found that I was not enjoying myself, I completed my PhD as an MPhil and tried a change of careers. I tried working as a property manager, initially remotely before moving to America in order to work hands-on with the properties. However, I found that I missed the stimulation of research and working with the passionate kind of people that research projects always attracts.
Working for EMERGE gives me the satisfaction of knowing I am supporting research that I care about in a field that directly impacts people in need. Equipped with a more academic orientated background, I am excited to bring a different point of view to the team while I learn more about clinical research.
This trial is an open label two-arm randomised trial focused on identifying the best treatment for community acquired sepsis patients. We will be investigating the feasibility of delivering early intravenous fluid resuscitation by comparing 5% human albumin solution (HAS) to balanced crystalloid. Currently, balanced crystalloids are used as routine care and the first line therapy in the international sepsis guidelines, whereas HAS is the second line fluid therapy in septic shock. Although, studies are showing that HAS may have further potential benefits to patients with sepsis.
ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)